Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to JONASCH, ERIC
Item TypeName
Academic Article Impact of tyrosine kinase inhibitors on the incidence of brain metastasis in metastatic renal cell carcinoma.
Academic Article Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease.
Concept Pyrroles
Academic Article Clinical outcomes for patients with metastatic renal cell carcinoma treated with alternative sunitinib schedules.
Academic Article Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.
Academic Article Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
Academic Article Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma.
Academic Article Rapid angiogenesis onset after discontinuation of sunitinib treatment of renal cell carcinoma patients.
Academic Article A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma.
Academic Article Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
Academic Article Molecular markers to predict response to therapy.
Academic Article Treatment patterns in metastatic renal cell carcinoma: a retrospective review of medical records from US community oncology practices.
Academic Article Alternate sunitinib schedules in patients with metastatic renal cell carcinoma.
Academic Article Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma.
Academic Article Hypertension and Circulating Cytokines and Angiogenic Factors in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma Treated With Sunitinib: Results From a Phase II Trial.
Academic Article Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma.
Academic Article Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinoma.
Academic Article Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.
Academic Article Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.
Academic Article Comparative effectiveness of everolimus and axitinib as second targeted therapies for metastatic renal cell carcinoma in the US: a retrospective chart review.
Academic Article Response to post-axitinib treatment in patients with metastatic renal cell carcinoma.
Academic Article Real-world dosing and drug costs with everolimus or axitinib as second targeted therapies for advanced renal cell carcinoma: a retrospective chart review in the US.
Search Criteria
  • Pyrroles